Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of CanSino Biologics's Pneumococcal Vaccine?
Pneumococcal Vaccine is a subunit vaccine commercialized by CanSino Biologics, with a leading Phase I program in Streptococcal Pneumonia. According...